CDC study ranks Moderna vaccine tops for preventing COVID-19 hospitalizations
 
The Centers for Disease Control and Prevention today revealed the comparative effectiveness of the three Food and Drug Administration-authorized COVID-19 vaccines, with Moderna’s vaccine deemed most effective at preventing hospitalizations. Moderna’s vaccine was 93% effective during a five-month period in preventing hospitalizations among adults without immunocompromised conditions in the U.S., compared to Pfizer (88%) and Johnson & Johnson (71%). Despite the rankings, the study authors maintained that all three vaccines provide “substantial” protection against COVID-19 hospitalization.
Related News Articles
Headline
  A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
  Headline
  The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
  Headline
  The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
  Headline
  The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
  Headline
  The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
  Headline
  The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
  